EA036750B1 - Лиофилизированная парентеральная композиция тигециклина и способ ее приготовления - Google Patents

Лиофилизированная парентеральная композиция тигециклина и способ ее приготовления Download PDF

Info

Publication number
EA036750B1
EA036750B1 EA201891587A EA201891587A EA036750B1 EA 036750 B1 EA036750 B1 EA 036750B1 EA 201891587 A EA201891587 A EA 201891587A EA 201891587 A EA201891587 A EA 201891587A EA 036750 B1 EA036750 B1 EA 036750B1
Authority
EA
Eurasian Patent Office
Prior art keywords
tigecycline
solution
lyophilized
sodium
composition
Prior art date
Application number
EA201891587A
Other languages
English (en)
Russian (ru)
Other versions
EA201891587A1 (ru
Inventor
Митеш Натаварлал Пател
Мафатлал Трибховандас Даве
Пранавкумар Джаиеш Чокси
Original Assignee
Гуфик Байосайенсиз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гуфик Байосайенсиз Лимитед filed Critical Гуфик Байосайенсиз Лимитед
Publication of EA201891587A1 publication Critical patent/EA201891587A1/ru
Publication of EA036750B1 publication Critical patent/EA036750B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EA201891587A 2016-01-08 2016-04-01 Лиофилизированная парентеральная композиция тигециклина и способ ее приготовления EA036750B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201621000791 2016-01-08
PCT/IN2016/050104 WO2017118994A1 (fr) 2016-01-08 2016-04-01 Composition parentérale lyophilisée de tigécycline et procédé de préparation associé

Publications (2)

Publication Number Publication Date
EA201891587A1 EA201891587A1 (ru) 2018-12-28
EA036750B1 true EA036750B1 (ru) 2020-12-16

Family

ID=59273613

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201891587A EA036750B1 (ru) 2016-01-08 2016-04-01 Лиофилизированная парентеральная композиция тигециклина и способ ее приготовления

Country Status (4)

Country Link
EP (1) EP3302494A4 (fr)
EA (1) EA036750B1 (fr)
WO (1) WO2017118994A1 (fr)
ZA (1) ZA201804834B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018013584A (es) 2016-05-09 2019-04-01 Xellia Pharmaceuticals Aps Formulaciones de antibioticos glicopeptidicos estabilizados.
KR102022338B1 (ko) * 2018-08-06 2019-09-18 이건무 당과 아미노산을 함유하는 안정한 수액제 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006055264A1 (fr) * 2004-11-03 2006-05-26 Curagen Corporation Formulations, procedes de production et utilisations du fgf-20
EP2881109A1 (fr) * 2012-03-22 2015-06-10 Galenicum Health S.L. Composition de tigecycline destinée à être injectée

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013078554A1 (fr) * 2011-12-02 2013-06-06 University Health Network Compositions de tigécycline et leurs utilisations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006055264A1 (fr) * 2004-11-03 2006-05-26 Curagen Corporation Formulations, procedes de production et utilisations du fgf-20
EP2881109A1 (fr) * 2012-03-22 2015-06-10 Galenicum Health S.L. Composition de tigecycline destinée à être injectée

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JITKOVA et al. "A novel formulation of tigecycline has enhanced stability and sustained antibacterial and antileukemic activity", PLoS One, 28 May 2014, Vol. 9(5), pages 1-11. *Abstract; page 3, last paragraph; page 6* *
UEDA et al. "Evaluation of a sulfobutyl ether betacyclodextrin as asolubilizing/stabilizing agent for several drugs", Drug Development and Industrial Pharmacy, 1998, Vol. 24(9), pages 863-867. *The whole document* *

Also Published As

Publication number Publication date
EA201891587A1 (ru) 2018-12-28
EP3302494A1 (fr) 2018-04-11
WO2017118994A1 (fr) 2017-07-13
ZA201804834B (en) 2019-05-29
EP3302494A4 (fr) 2019-01-23

Similar Documents

Publication Publication Date Title
KR101354093B1 (ko) 티게사이클린 조성물 및 이의 제조방법
RU2647972C2 (ru) Тетрациклиновая композиция
US20140274992A1 (en) Ceftolozane pharmaceutical compositions
US9107929B2 (en) Stable parenteral formulations of tigecycline
EA036750B1 (ru) Лиофилизированная парентеральная композиция тигециклина и способ ее приготовления
US20170196899A1 (en) Stable pharmaceutical compositions
US9855335B2 (en) Tigecycline composition for injection
US11433115B2 (en) Glycopeptide antibiotics liquid formulations and methods and uses thereof
CN103356662B (zh) 注射用替加环素组合物及其制备方法
US9511145B2 (en) Stable tigecycline composition
EP4289419A1 (fr) Composition parentérale lyophilisée de tosylate d'omadcycline présentant une stabilité améliorée
JP2008534443A (ja) 新規な方法
JP2008540421A (ja) ワルファリン存在下でのチゲサイクリンの送達